<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39363208</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>03</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Identification and evaluation of candidate COVID-19 critical genes and medicinal drugs related to plasma cells.</ArticleTitle><Pagination><StartPage>1099</StartPage><MedlinePgn>1099</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1099</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-024-10000-3</ELocationID><Abstract><AbstractText>The ongoing COVID-19 pandemic, caused by the SARS-CoV-2 virus, represents one of the most significant global health crises in recent history. Despite extensive research into the immune mechanisms and therapeutic options for COVID-19, there remains a paucity of studies focusing on plasma cells. In this study, we utilized the DESeq2 package to identify differentially expressed genes (DEGs) between COVID-19 patients and controls using datasets GSE157103 and GSE152641. We employed the xCell algorithm to perform immune infiltration analyses, revealing notably elevated levels of plasma cells in COVID-19 patients compared to healthy individuals. Subsequently, we applied the Weighted Gene Co-expression Network Analysis (WGCNA) algorithm to identify COVID-19 related plasma cell module genes. Further, positive cluster biomarker genes for plasma cells were extracted from single-cell RNA sequencing data (GSE171524), leading to the identification of 122 shared genes implicated in critical biological processes such as cell cycle regulation and viral infection pathways. We constructed a robust protein-protein interaction (PPI) network comprising 89 genes using Cytoscape, and identified 20 hub genes through cytoHubba. These genes were validated in external datasets (GSE152418 and GSE179627). Additionally, we identified three potential small molecules (GSK-1070916, BRD-K89997465, and idarubicin) that target key hub genes in the network, suggesting a novel therapeutic approach. These compounds were characterized by their ability to down-regulate AURKB, KIF11, and TOP2A effectively, as evidenced by their low free binding energies determined through computational analyses using cMAP and AutoDock. This study marks the first comprehensive exploration of plasma cells' role in COVID-19, offering new insights and potential therapeutic targets. It underscores the importance of a systematic approach to understanding and treating COVID-19, expanding the current body of knowledge and providing a foundation for future research.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhe</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Institute for Hepatology, The Second Affiliated Hospital, School of Medicine, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, Guangdong Province, 518112, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computer Science, City University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petinrin</LastName><ForeName>Olutomilayo Olayemi</ForeName><Initials>OO</Initials><AffiliationInfo><Affiliation>Department of Computer Science, City University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Nanjun</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Computer Science, City University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toseef</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Computer Science, City University of Hong Kong, Hong Kong, Hong Kong SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Rocgene (Beijing) Technology Co., Ltd, Beijing, Beijing, 102200, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Zhongxu</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>HIM-BGI Omics Center, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China. zhuzhongxu@him.cas.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Furong</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute for Hepatology, The Second Affiliated Hospital, School of Medicine, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, Southern University of Science and Technology, Shenzhen, Guangdong Province, 518112, China. qifurong2012@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Ka-Chun</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>Department of Computer Science, City University of Hong Kong, Hong Kong, Hong Kong SAR, China. kc.w@cityu.edu.hk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shenzhen Research Institute, City University of Hong Kong, Shenzhen, China. kc.w@cityu.edu.hk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>32170654</GrantID><Agency>National Natural Science Foundation of China</Agency><Country /></Grant><Grant><GrantID>11203723</GrantID><Agency>Research Grants Council of the Hong Kong Special Administrative Region</Agency><Country /></Grant><Grant><GrantID>ITB/FBL/9037/22/S</GrantID><Agency>Innovation and Technology Commission</Agency><Country /></Grant><Grant><GrantID>2021SIRG036</GrantID><Agency>Strategic Interdisciplinary Research Grant of City University of Hong Kong</Agency><Country /></Grant><Grant><GrantID>11203221</GrantID><Agency>City University of Hong Kong</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010950" MajorTopicYN="Y">Plasma Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="N">COVID-19 Drug Treatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060066" MajorTopicYN="N">Protein Interaction Maps</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053263" MajorTopicYN="N">Gene Regulatory Networks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Hub genes</Keyword><Keyword MajorTopicYN="N">Plasma cells</Keyword><Keyword MajorTopicYN="N">ScRNA-seq</Keyword><Keyword MajorTopicYN="N">WGCNA</Keyword></KeywordList><CoiStatement>All authors disclosed no relevant relationships. The authors reported no potential conflicts of interest. The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>8</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>23</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39363208</ArticleId><ArticleId IdType="pmc">PMC11451256</ArticleId><ArticleId IdType="doi">10.1186/s12879-024-10000-3</ArticleId><ArticleId IdType="pii">10.1186/s12879-024-10000-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kambouris ME. Global catastrophic biological risks in the post-COVID-19 World: Time to act is now. OMICS. 2023;27:153–70. 10.1089/omi.2022.0178.</Citation><ArticleIdList><ArticleId IdType="pubmed">36946656</ArticleId></ArticleIdList></Reference><Reference><Citation>Kupferschmidt K, Cohen J. Will novel virus go pandemic or be contained? Science. 2020;367:610–1. 10.1126/science.367.6478.610.</Citation><ArticleIdList><ArticleId IdType="pubmed">32029604</ArticleId></ArticleIdList></Reference><Reference><Citation>Guery B, Poissy J, el Mansouf L, Séjourné C, Ettahar N, Lemaire X, Vuotto F, Goffard A, Behillil S, Enouf V, Caro V, Mailles A, Che D, Manuguerra J-C, Mathieu D, Fontanet A, van der Werf S. MERS-CoV study group, clinical features and viral diagnosis of two cases of infection with middle east respiratory syndrome coronavirus: a report of nosocomial transmission. Lancet. 2013;381:2265–72. 10.1016/S0140-6736(13)60982-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159298</ArticleId><ArticleId IdType="pubmed">23727167</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan JF-W, Yuan S, Kok K-H, To KK-W, Chu H, Yang J, Xing F, Liu J, Yip CC-Y, Poon RW-S, Tsoi H-W, Lo SK-F, Chan K-H, Poon VK-M, Chan W-M, Ip JD, Cai J-P, Cheng VC-C, Chen H, Hui CK-M, Yuen K-Y. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395:514–23. 10.1016/S0140-6736(20)30154-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159286</ArticleId><ArticleId IdType="pubmed">31986261</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison AG, Lin T, Wang P. Mechanisms of SARS-CoV-2 transmission and Pathogenesis. Trends Immunol. 2020;41:1100–15. 10.1016/j.it.2020.10.004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7556779</ArticleId><ArticleId IdType="pubmed">33132005</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-infected pneumonia in Wuhan. China JAMA. 2020;323:1061–9. 10.1001/jama.2020.1585.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–13. 10.1016/S0140-6736(20)30211-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning Q, Wu D, Wang X, Xi D, Chen T, Chen G, Wang H, Lu H, Wang M, Zhu L, Hu J, Liu T, Ma K, Han M, Luo X. The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication. Signal Transduct Target Ther. 2022;7:57. 10.1038/s41392-022-00907-1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8863906</ArticleId><ArticleId IdType="pubmed">35197452</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers MM, Haagmans BL. SARS-CoV-2 pathogenesis. Nat Rev Microbiol. 2022;20:270–84. 10.1038/s41579-022-00713-0.</Citation><ArticleIdList><ArticleId IdType="pubmed">35354968</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren X, Wang S, Chen X, Wei X, Li G, Ren S, Zhang T, Zhang X, Lu Z, You Z, Wang Z, Song N, Qin C. Multiple expression assessments of ACE2 and TMPRSS2 SARS-CoV-2 Entry molecules in the urinary tract and their associations with Clinical manifestations of COVID-19. Infect Drug Resist. 2020;13:3977–90. 10.2147/IDR.S270543.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7650837</ArticleId><ArticleId IdType="pubmed">33177848</ArticleId></ArticleIdList></Reference><Reference><Citation>Senapati S, Banerjee P, Bhagavatula S, Kushwaha PP, Kumar S. Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19. J Genet. 2021;100:100. 10.1007/s12041-021-01262-w.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7904510</ArticleId><ArticleId IdType="pubmed">33707363</ArticleId></ArticleIdList></Reference><Reference><Citation>Serpeloni JM, Lima Neto QA, Lucio LC, Ramão A, Carvalho de Oliveira J, Gradia DF, Malheiros D, Ferrasa A, Marchi R, Figueiredo DLA, Silva WA, Ribeiro EMSF, Cólus IMS, Cavalli LR. Genome interaction of the virus and the host genes and non-coding RNAs in SARS-CoV-2 infection. Immunobiology. 2021;226:152130. 10.1016/j.imbio.2021.152130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8378551</ArticleId><ArticleId IdType="pubmed">34425415</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S-W, Wang S-F. SARS-CoV-2 entry related viral and host genetic variations: implications on COVID-19 severity, Immune escape, and infectivity. Int J Mol Sci. 2021;22(6):3060. 10.3390/ijms22063060.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8002537</ArticleId><ArticleId IdType="pubmed">33802729</ArticleId></ArticleIdList></Reference><Reference><Citation>de Pondé RA. Physicochemical effects of emerging exchanges on the spike protein’s RBM of the SARS-CoV-2 Omicron subvariants BA.1-BA.5 and its influence on the biological properties and attributes developed by these subvariants. Virology. 2023;587:109850. 10.1016/j.virol.2023.109850.</Citation><ArticleIdList><ArticleId IdType="pubmed">37562286</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua RL, Lukassen S, Trump S, Hennig BP, Wendisch D, Pott F, Debnath O, Thürmann L, Kurth F, Völker MT, Kazmierski J, Timmermann B, Twardziok S, Schneider S, Machleidt F, Müller-Redetzky H, Maier M, Krannich A, Schmidt S, Balzer F, Liebig J, Loske J, Suttorp N, Eils J, Ishaque N, Liebert UG, von Kalle C, Hocke A, Witzenrath M, Goffinet C, Drosten C, Laudi S, Lehmann I, Conrad C, Sander L-E, Eils R. COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis. Nat Biotechnol. 2020;38:970–9. 10.1038/s41587-020-0602-4.</Citation><ArticleIdList><ArticleId IdType="pubmed">32591762</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler ES, Bailey AL, Kafai NM, Nair S, McCune BT, Yu J, Fox JM, Chen RE, Earnest JT, Keeler SP, Ritter JH, Kang L-I, Dort S, Robichaud A, Head R, Holtzman MJ, Diamond MS. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nat Immunol. 2020;21:1327–35. 10.1038/s41590-020-0778-2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7578095</ArticleId><ArticleId IdType="pubmed">32839612</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerapio JP, Perrier M, Pont F, Tosolini M, Laurent C, Bertani S, Fournie J-J. Single-cell RNAseq profiling of human γδ T lymphocytes in Virus-related cancers and COVID-19 disease. Viruses. 2021;13:13. 10.3390/v13112212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8623150</ArticleId><ArticleId IdType="pubmed">34835019</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreras C, Pascual-Miguel B, Mestre-Durán C, Navarro-Zapata A, Clares-Villa L, Martín-Cortázar C, De Paz R, Marcos A, Vicario JL, Balas A, García-Sánchez F, Eguizabal C, Solano C, Mora-Rillo M, Soria B, Pérez-Martínez A. SARS-CoV-2-Specific memory T lymphocytes from COVID-19 convalescent donors: identification, Biobanking, and large-scale production for adoptive cell therapy. Front Cell Dev Biol. 2021;9:620730. 10.3389/fcell.2021.620730.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7947351</ArticleId><ArticleId IdType="pubmed">33718360</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoodpoor A, Hosseini M, Soltani-Zangbar S, Sanaie S, Aghebati-Maleki L, Saghaleini SH, Ostadi Z, Hajivalili M, Bayatmakoo Z, Haji-Fatahaliha M, Babaloo Z, Farid SS, Heris JA, Roshangar L, Rikhtegar R, Kafil HS, Yousefi M. Reduction and exhausted features of T lymphocytes under serological changes, and prognostic factors in COVID-19 progression. Mol Immunol. 2021;138:121–7. 10.1016/j.molimm.2021.06.001.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8343383</ArticleId><ArticleId IdType="pubmed">34392110</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenoglio D, Dentone C, Parodi A, Di Biagio A, Bozzano F, Vena A, Fabbi M, Ferrera F, Altosole T, Bruzzone B, Giacomini M, Pelosi P, De Maria A, Bassetti M, De Palma R, Filaci G. Characterization of T lymphocytes in severe COVID-19 patients. J Med Virol. 2021;93:5608–13. 10.1002/jmv.27037.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8242373</ArticleId><ArticleId IdType="pubmed">33913544</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasizadeh R, Aghbash PS, Nahand JS, Entezari-Maleki T, Baghi HB. SARS-CoV-2-associated organs failure and inflammation: a focus on the role of cellular and viral microRNAs. Virol J. 2023;20:179. 10.1186/s12985-023-02152-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10413769</ArticleId><ArticleId IdType="pubmed">37559103</ArticleId></ArticleIdList></Reference><Reference><Citation>Vályi-Nagy I, Uher F, Rákóczi É, Szekanecz Z. Adaptive immunity to viruses: what did we learn from SARS-CoV-2 infection? Int J Mol Sci. 2022;23:13951. 10.3390/ijms232213951.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9694482</ArticleId><ArticleId IdType="pubmed">36430430</ArticleId></ArticleIdList></Reference><Reference><Citation>Meidaninikjeh S, Sabouni N, Marzouni HZ, Bengar S, Khalili A, Jafari R. Monocytes and macrophages in COVID-19: friends and foes. Life Sci. 2021;269:119010. 10.1016/j.lfs.2020.119010</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834345</ArticleId><ArticleId IdType="pubmed">33454368</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B, Horvath S. A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol. 2005;4:Article17. 10.2202/1544-6115.1128.</Citation><ArticleIdList><ArticleId IdType="pubmed">16646834</ArticleId></ArticleIdList></Reference><Reference><Citation>Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559. 10.1186/1471-2105-9-559.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2631488</ArticleId><ArticleId IdType="pubmed">19114008</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu C, Li C, Wang W, Yan W, Yao Y, Shi M, Han F, Shang A. Immune Infiltration and N(6)-Methyladenosine ncRNA isoform detection in Acute Lung Injury. J Oncol. 2022;2022(3922299):1. 10.1155/2022/3922299.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9262529</ArticleId><ArticleId IdType="pubmed">35813860</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Q, Wang Y, Yang D, Guo S, Li X, Dong J, Wan C, Shen Y, Wen F. Identification of hub genes and key pathways in the emphysema phenotype of COPD. Aging. 2021;13:5120–35. 10.18632/aging.202432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7950259</ArticleId><ArticleId IdType="pubmed">33535173</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong X, Sun H, Wei K, Meng L, Lv X, Liu C, Lin F, Gu X. WGCNA combined with machine learning algorithms for analyzing key genes and immune cell infiltration in heart failure due to ischemic cardiomyopathy. Front Cardiovasc Med. 2023;10:1058834. 10.3389/fcvm.2023.1058834.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10064046</ArticleId><ArticleId IdType="pubmed">37008314</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo J, Yu H, Yang J, Li Y, Zhang X, Mei K, Chi S, Yuan S, Liu H, El-Ashram S, Huang S, Wen F. Weighted gene co-expression network analysis revealed host transcriptional response to H1N1 influenza a virus infection. J Infect. 2021;82:e4-7. 10.1016/j.jinf.2020.12.017.</Citation><ArticleIdList><ArticleId IdType="pubmed">33359050</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasankhani A, Bahrami A, Sheybani N, Aria B, Hemati B, Fatehi F, Ghaem Maghami Farahani H, Javanmard G, Rezaee M, Kastelic JP, Barkema HW. Differential co-expression network analysis reveals key hub-high traffic genes as potential therapeutic targets for COVID-19 pandemic. Front Immunol. 2021;12:789317. 10.3389/fimmu.2021.789317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8714803</ArticleId><ArticleId IdType="pubmed">34975885</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing S, Tian J, Zhang Y, Chen X, Zheng S. Identification of a new pseudogenes/lncRNAs-hsa-miR-26b-5p-COL12A1 competing endogenous RNA network associated with prognosis of pancreatic cancer using bioinformatics analysis. Aging. 2020;12:19107–28. 10.18632/aging.103709.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7732303</ArticleId><ArticleId IdType="pubmed">33027767</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Ye X, An Z, Zhao Z. The challenges and opportunities of scRNA-seq in COVID-19 research and clinical translation. Virol J. 2022;19:217. 10.1186/s12985-022-01923-x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9753867</ArticleId><ArticleId IdType="pubmed">36522785</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren X, Wen W, Fan X, Hou W, Su B, Cai P, Li J, Liu Y, Tang F, Zhang F, Yang Y, He J, Ma W, He J, Wang P, Cao Q, Chen F, Chen Y, Cheng X, Deng G, Deng X, Ding W, Feng Y, Gan R, Guo C, Guo W, He S, Jiang C, Liang J, Li Y-M, Lin J, Ling Y, Liu H, Liu J, Liu N, Liu S-Q, Luo M, Ma Q, Song Q, Sun W, Wang G, Wang F, Wang Y, Wen X, Wu Q, Xu G, Xie X, Xiong X, Xing X, Xu H, Yin C, Yu D, Yu K, Yuan J, Zhang B, Zhang P, Zhang T, Zhao J, Zhao P, Zhou J, Zhou W, Zhong S, Zhong X, Zhang S, Zhu L, Zhu P, Zou B, Zou J, Zuo Z, Bai F, Huang X, Zhou P, Jiang Q, Huang Z, Bei J-X, Wei L, Bian X-W, Liu X, Cheng T, Li X, Zhao P, Wang F-S, Wang H, Su B, Zhang Z, Qu K, Wang X, Chen J, Jin R, Zhang Z. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas. Cell. 2021;184:1895–913.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857060</ArticleId><ArticleId IdType="pubmed">33657410</ArticleId></ArticleIdList></Reference><Reference><Citation>Dudchenko O, Ordovas-Montanes J, Bingle CD. Respiratory epithelial cell types, states and fates in the era of single-cell RNA-sequencing. Biochem J. 2023;480:921–39. 10.1042/BCJ20220572.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10422933</ArticleId><ArticleId IdType="pubmed">37410389</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Lin D, Li K, Ding X, Li L, Liu Y, Liu D, Lin J, Teng X, Li Y, Liu M, Shen J, Wang X, He D, Shi Y, Wang D, Xu J. Transcriptome analysis of Peripheral Blood mononuclear cells reveals distinct Immune response in asymptomatic and re-detectable positive COVID-19 patients. Front Immunol. 2021;12:716075. 10.3389/fimmu.2021.716075.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8359015</ArticleId><ArticleId IdType="pubmed">34394120</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dam S, Võsa U, van der Graaf A, Franke L, de Magalhães JP. Gene co-expression analysis for functional classification and gene-disease predictions. Brief Bioinform. 2018;19:575–92. 10.1093/bib/bbw139.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6054162</ArticleId><ArticleId IdType="pubmed">28077403</ArticleId></ArticleIdList></Reference><Reference><Citation>Navitha Reddy G, Jogvanshi A, Naikwadi S, Sonti R. Nirmatrelvir and Ritonavir combination: an antiviral therapy for COVID-19. Expert Rev Anti Infect Ther. 2023;21(9):943–55. 10.1080/14787210.2023.2241638.</Citation><ArticleIdList><ArticleId IdType="pubmed">37525997</ArticleId></ArticleIdList></Reference><Reference><Citation>Owen DR, Allerton CMN, Anderson AS, Aschenbrenner L, Avery M, Berritt S, Boras B, Cardin RD, Carlo A, Coffman KJ, Dantonio A, Di L, Eng H, Ferre R, Gajiwala KS, Gibson SA, Greasley SE, Hurst BL, Kadar EP, Kalgutkar AS, Lee JC, Lee J, Liu W, Mason SW, Noell S, Novak JJ, Obach RS, Ogilvie K, Patel NC, Pettersson M, Rai DK, Reese MR, Sammons MF, Sathish JG, Singh RSP, Steppan CM, Stewart AE, Tuttle JB, Updyke L, Verhoest PR, Wei L, Yang Q, Zhu Y. An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19. Science. 2021;374:1586–93. 10.1126/science.abl4784.</Citation><ArticleIdList><ArticleId IdType="pubmed">34726479</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandyck K, Deval J. Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection. Curr Opin Virol. 2021;49:36–40. 10.1016/j.coviro.2021.04.006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8075814</ArticleId><ArticleId IdType="pubmed">34029993</ArticleId></ArticleIdList></Reference><Reference><Citation>Marzi M, Vakil MK, Bahmanyar M, Zarenezhad E. Paxlovid: mechanism of action, synthesis, and in Silico Study. Biomed Res Int. 2022;2022:7341493. 10.1155/2022/7341493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9283023</ArticleId><ArticleId IdType="pubmed">35845944</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian H, Yang C, Song T, Zhou K, Wen L, Tian Y, Tang L, Xu W, Zhang X. Efficacy and safety of paxlovid (nirmatrelvir/ritonavir) in the treatment of COVID-19: an updated meta-analysis and trial sequential analysis. Rev Med Virol. 2023;33(5):e2473.</Citation><ArticleIdList><ArticleId IdType="pubmed">37485774</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamb YN, Ritonavir NP. First Approval. Drugs. 2022;82:585–91. 10.1007/s40265-022-01692-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8933659</ArticleId><ArticleId IdType="pubmed">35305258</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhvlediani T, Bernard-Valnet R, Dias SP, Eikeland R, Pfausler B, Sellner J. Infectious disease panel of the European Academy of Neurology, neurological side effects and drug interactions of antiviral compounds against SARS-CoV-2. Eur J Neurol. 2023;30(12):3904–12. 10.1111/ene.16017.</Citation><ArticleIdList><ArticleId IdType="pubmed">37526048</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashemian SMR, Sheida A, Taghizadieh M, Memar MY, Hamblin MR, Bannazadeh Baghi H, Sadri Nahand J, Asemi Z, Mirzaei H. Paxlovid (Nirmatrelvir/Ritonavir): a new approach to Covid-19 therapy? Biomed Pharmacother. 2023;162:114367. 10.1016/j.biopha.2023.114367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9899776</ArticleId><ArticleId IdType="pubmed">37018987</ArticleId></ArticleIdList></Reference><Reference><Citation>Loos NHC, Beijnen JH, Schinkel AH. The inhibitory and inducing effects of ritonavir on hepatic and intestinal CYP3A and other drug-handling proteins. Biomed Pharmacother. 2023;162:114636. 10.1016/j.biopha.2023.114636.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10065864</ArticleId><ArticleId IdType="pubmed">37004323</ArticleId></ArticleIdList></Reference><Reference><Citation>Nappi F, Iervolino A, Avtaar Singh SS. Molecular insights of SARS-CoV-2 antivirals Administration: a balance between Safety profiles and Impact on Cardiovascular phenotypes. Biomedicines. 2022;10(2):437. 10.3390/biomedicines10020437.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8962379</ArticleId><ArticleId IdType="pubmed">35203646</ArticleId></ArticleIdList></Reference><Reference><Citation>Haque OI, Mahar S, Hussain S, Sloane P. Pharmacokinetic interaction between verapamil and ritonavir-boosted nirmatrelvir: implications for the management of COVID-19 in patients with hypertension. BMJ Case Rep. 2023;16(1):e252677. 10.1136/bcr-2022-252677.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9843211</ArticleId><ArticleId IdType="pubmed">36639196</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen HC, Sharma P. Histology, Plasma Cells. 2023.</Citation><ArticleIdList><ArticleId IdType="pubmed">32310542</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, Zhou M, Chen L, Meng S, Hu Y, Peng C, Yuan M, Huang J, Wang Z, Yu J, Gao X, Wang D, Yu X, Li L, Zhang J, Wu X, Li B, Xu Y, Chen W, Peng Y, Hu Y, Lin L, Liu X, Huang S, Zhou Z, Zhang L, Wang Y, Zhang Z, Deng K, Xia Z, Gong Q, Zhang W, Zheng X, Liu Y, Yang H, Zhou D, Yu D, Hou J, Shi Z, Chen S, Chen Z, Zhang X, Yang X. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci U S A. 2020;117:9490–6. 10.1073/pnas.2004168117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7196837</ArticleId><ArticleId IdType="pubmed">32253318</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowe JE. Principles of broad and potent antiviral human antibodies: insights for vaccine design. Cell Host Microbe. 2017;22:193–206. 10.1016/j.chom.2017.07.013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5700460</ArticleId><ArticleId IdType="pubmed">28799905</ArticleId></ArticleIdList></Reference><Reference><Citation>Roback JD, Guarner J. Convalescent plasma to treat COVID-19: possibilities and challenges. JAMA. 2020;323:1561–2. 10.1001/jama.2020.4940.</Citation><ArticleIdList><ArticleId IdType="pubmed">32219429</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato S, Hosokawa T, Kawashima H. Successful treatment of plasma exchange for refractory systemic juvenile idiopathic arthritis complicated with macrophage activation syndrome and severe lung disease. Ann Rheum Dis. 2022;81:e61. 10.1136/annrheumdis-2020-217390.</Citation><ArticleIdList><ArticleId IdType="pubmed">32245894</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz AR, Fiebig L, Hirseland H, Diekmann L-M, Reinke S, Hardt S, Niedobitek A, Mei HE. SARS-CoV-2 specific plasma cells acquire long-lived phenotypes in human bone marrow. EBioMedicine. 2023;95:104735. 10.1016/j.ebiom.2023.104735.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10432952</ArticleId><ArticleId IdType="pubmed">37556944</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner JS, Kim W, Kalaidina E, Goss CW, Rauseo AM, Schmitz AJ, Hansen L, Haile A, Klebert MK, Pusic I, O’Halloran JA, Presti RM, Ellebedy AH. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans. Nature. 2021;595:421–5. 10.1038/s41586-021-03647-4.</Citation><ArticleIdList><ArticleId IdType="pubmed">34030176</ArticleId></ArticleIdList></Reference><Reference><Citation>Banji D, Alqahtani SS, Banji OJF, Machanchery S, Shoaib A. Calming the inflammatory storm in severe COVID-19 infections: role of biologics- A narrative review. Saudi Pharm J. 2021;29:213–22. 10.1016/j.jsps.2021.01.005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8030716</ArticleId><ArticleId IdType="pubmed">33850422</ArticleId></ArticleIdList></Reference><Reference><Citation>Sosa-Hernández VA, Torres-Ruíz J, Cervantes-Díaz R, Romero-Ramírez S, Páez-Franco JC, Meza-Sánchez DE, Juárez-Vega G, Pérez-Fragoso A, Ortiz-Navarrete V, Ponce-de-León A, Llorente L, Berrón-Ruiz L, Mejía-Domínguez NR, Gómez-Martín D, Maravillas-Montero JL. B cell subsets as severity-associated signatures in COVID-19 patients. Front Immunol. 2020;11:611004. 10.3389/fimmu.2020.611004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7744304</ArticleId><ArticleId IdType="pubmed">33343585</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannotta G, Giannotta N. mRNA. COVID-19 vaccines and long-lived plasma cells: a complicated relationship. Vaccines (Basel). 2021;9(12):1503. 10.3390/vaccines9121503.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8703557</ArticleId><ArticleId IdType="pubmed">34960249</ArticleId></ArticleIdList></Reference><Reference><Citation>Tehrani ZR, Habibzadeh P, Flinko R, Chen H, Abbasi A, Yared JA, Ciupe SM, Lewis GK, Sajadi MM. Deficient generation of spike-specific long-lived plasma cells in the bone marrow after severe acute respiratory syndrome coronavirus 2 infection. J Infect Dis. 2024;230(1):e30–3. 10.1093/infdis/jiad603.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11272043</ArticleId><ArticleId IdType="pubmed">39052732</ArticleId></ArticleIdList></Reference><Reference><Citation>Overmyer KA, Shishkova E, Miller IJ, Balnis J, Bernstein MN, Peters-Clarke TM, Meyer JG, Quan Q, Muehlbauer LK, Trujillo EA, He Y, Chopra A, Chieng HC, Tiwari A, Judson MA, Paulson B, Brademan DR, Zhu Y, Serrano LR, Linke V, Drake LA, Adam AP, Schwartz BS, Singer HA, Swanson S, Mosher DF, Stewart R, Coon JJ, Jaitovich A. Large-scale multi-omic analysis of COVID-19 severity. Cell Syst. 2021;12:23-e407. 10.1016/j.cels.2020.10.003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543711</ArticleId><ArticleId IdType="pubmed">33096026</ArticleId></ArticleIdList></Reference><Reference><Citation>Thair SA, He YD, Hasin-Brumshtein Y, Sakaram S, Pandya R, Toh J, Rawling D, Remmel M, Coyle S, Dalekos GN, Koutsodimitropoulos I, Vlachogianni G, Gkeka E, Karakike E, Damoraki G, Antonakos N, Khatri P, Giamarellos-Bourboulis EJ, Sweeney TE. Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections. IScience. 2021;24:101947. 10.1016/j.isci.2020.101947.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7786129</ArticleId><ArticleId IdType="pubmed">33437935</ArticleId></ArticleIdList></Reference><Reference><Citation>Melms JC, Biermann J, Huang H, Wang Y, Nair A, Tagore S, Katsyv I, Rendeiro AF, Amin AD, Schapiro D, Frangieh CJ, Luoma AM, Filliol A, Fang Y, Ravichandran H, Clausi MG, Alba GA, Rogava M, Chen SW, Ho P, Montoro DT, Kornberg AE, Han AS, Bakhoum MF, Anandasabapathy N, Suárez-Fariñas M, Bakhoum SF, Bram Y, Borczuk A, Guo XV, Lefkowitch JH, Marboe C, Lagana SM, Del Portillo A, Tsai EJ, Zorn E, Markowitz GS, Schwabe RF, Schwartz RE, Elemento O, Saqi A, Hibshoosh H, Que J, Izar B. A molecular single-cell lung atlas of lethal COVID-19. Nature. 2021;595:114–9. 10.1038/s41586-021-03569-1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8814825</ArticleId><ArticleId IdType="pubmed">33915568</ArticleId></ArticleIdList></Reference><Reference><Citation>Arunachalam PS, Wimmers F, Mok CKP, Perera RAPM, Scott M, Hagan T, Sigal N, Feng Y, Bristow L, Tak-Yin Tsang O, Wagh D, Coller J, Pellegrini KL, Kazmin D, Alaaeddine G, Leung WS, Chan JMC, Chik TSH, Choi CYC, Huerta C, Paine M, McCullough H, Lv E, Anderson S, Edupuganti AA, Upadhyay SE, Bosinger HT, Maecker P, Khatri N, Rouphael M, Peiris B, Pulendran. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science. 2020;369:1210–20. 10.1126/science.abc6261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665312</ArticleId><ArticleId IdType="pubmed">32788292</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284–7. 10.1089/omi.2011.0118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3339379</ArticleId><ArticleId IdType="pubmed">22455463</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, Feng T, Zhou L, Tang W, Zhan L, Fu X, Liu S, Bo X, Yu G. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (Camb). 2021;2(3):100141. 10.1016/j.xinn.2021.100141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8454663</ArticleId><ArticleId IdType="pubmed">34557778</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W, Anders S. Moderated estimation of Fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. 10.1186/s13059-014-0550-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoué F, Bruneval P, Cugnenc P-H, Trajanoski Z, Fridman W-H, Pagès F. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006;313:1960–4. 10.1126/science.1129139.</Citation><ArticleIdList><ArticleId IdType="pubmed">17008531</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012;21:309–22. 10.1016/j.ccr.2012.02.022.</Citation><ArticleIdList><ArticleId IdType="pubmed">22439926</ArticleId></ArticleIdList></Reference><Reference><Citation>Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18:220. 10.1186/s13059-017-1349-1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5688663</ArticleId><ArticleId IdType="pubmed">29141660</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Yang C, Pan C, Feng X, Lei Z, Huang J, Wei X, Li F, Ma Y. Identification of key genes and functional enrichment pathways involved in fat deposition in Xinyang buffalo by WGCNA. Gene. 2022;818:146225. 10.1016/j.gene.2022.146225.</Citation><ArticleIdList><ArticleId IdType="pubmed">35063576</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahan R, Zawora C, Wight H, Sittmann J, Wang W, Mount SM, Liu Z. Consensus Coexpression Network Analysis Identifies Key Regulators of Flower and Fruit Development in Wild Strawberry. Plant Physiol. 2018;178:202–16. 10.1104/pp.18.00086.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6130042</ArticleId><ArticleId IdType="pubmed">29991484</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Luo J, Liu Z, Liu X, Ma Y, Zhang B, Chen Y, Li X, Feng Z, Yang N, Feng D, Wang L, Song X. Identification of hub genes in colorectal cancer based on weighted gene co-expression network analysis and clinical data from the Cancer Genome Atlas. Biosci Rep. 2021;41:41. 10.1042/BSR20211280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8314434</ArticleId><ArticleId IdType="pubmed">34308980</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Y, Hao S, Andersen-Nissen E, Mauck WM, Zheng S, Butler A, Lee MJ, Wilk AJ, Darby C, Zager M, Hoffman P, Stoeckius M, Papalexi E, Mimitou EP, Jain J, Srivastava A, Stuart T, Fleming LM, Yeung B, Rogers AJ, McElrath JM, Blish CA, Gottardo R, Smibert P, Satija R. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573-e358729. 10.1016/j.cell.2021.04.048.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8238499</ArticleId><ArticleId IdType="pubmed">34062119</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM, Hao Y, Stoeckius M, Smibert P, Satija R. Comprehensive Integration of single-cell data. Cel. 2019;177:1888-1902.e21. 10.1016/j.cell.2019.05.031.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6687398</ArticleId><ArticleId IdType="pubmed">31178118</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol. 2018;36:411–20. 10.1038/nbt.4096.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6700744</ArticleId><ArticleId IdType="pubmed">29608179</ArticleId></ArticleIdList></Reference><Reference><Citation>Satija R, Farrell JA, Gennert D, Schier AF, Regev A. Spatial reconstruction of single-cell gene expression data. Nat Biotechnol. 2015;33:495–502. 10.1038/nbt.3192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4430369</ArticleId><ArticleId IdType="pubmed">25867923</ArticleId></ArticleIdList></Reference><Reference><Citation>Fei X, Liu J, Xu J, Jing H, Cai Z, Yan J, Wu Z, Li H, Wang Z, Shen Y. Integrating spatial transcriptomics and single-cell RNA-sequencing reveals the alterations in epithelial cells during nodular formation in benign prostatic hyperplasia. J Transl Med. 2024;22:380. 10.1186/s12967-024-05212-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11036735</ArticleId><ArticleId IdType="pubmed">38654277</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia G, Zhu S, Liu Y, Pan J, Wang X, Shen C, Du A, Xu C. Transcriptomic profiling and regulatory pathways of cardiac resident macrophages in aging. Cell Mol Life Sci. 2024;81:220. 10.1007/s00018-024-05235-x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11102896</ArticleId><ArticleId IdType="pubmed">38763956</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathak E, Atri N, Mishra R. Single-cell transcriptome analysis reveals the role of pancreatic secretome in COVID-19 Associated multi-organ dysfunctions. Interdiscip Sci. 2022;14:863–78. 10.1007/s12539-022-00513-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8990272</ArticleId><ArticleId IdType="pubmed">35394619</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J-W, Shrestha L, Green G, Leier A, Marquez-Lago TT. The hitchhikers’ guide to RNA sequencing and functional analysis. Brief Bioinform. 2023;24(1):bbac529. 10.1093/bib/bbac529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9851315</ArticleId><ArticleId IdType="pubmed">36617463</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosati D, Palmieri M, Brunelli G, Morrione A, Iannelli F, Frullanti E, Giordano A. Differential gene expression analysis pipelines and bioinformatic tools for the identification of specific biomarkers: a review. Comput Struct Biotechnol J. 2024;23:1154–68. 10.1016/j.csbj.2024.02.018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10951429</ArticleId><ArticleId IdType="pubmed">38510977</ArticleId></ArticleIdList></Reference><Reference><Citation>WASWA Munawar, MH Elias, FH Addnan, P Hassandarvish, S AbuBakar, N Roslan. Gene expression profiling of host lipid metabolism in SARS-CoV-2 infected patients: a systematic review and integrated bioinformatics analysis., BMC Infect Dis. 2024;24(1):124. 10.1186/s12879-024-08983-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10807267</ArticleId><ArticleId IdType="pubmed">38263024</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Zhang Y, Bai K-X, Qi X-J, Zhao Y, Bu H. Bioinformatics screening of gene expression profile and diagnostic application of meningeal carcinoma. Eur Rev Med Pharmacol Sci. 2023;27:9601–13. 10.26355/eurrev_202310_34132.</Citation><ArticleIdList><ArticleId IdType="pubmed">37916326</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Singh SP. A study on the analysis of important gene networks and pathways involved in progression of endometriosis to ovarian endometrioma cyst. Appl Biochem Biotechnol. 2023;196(7):4352–65. 10.1007/s12010-023-04778-2.</Citation><ArticleIdList><ArticleId IdType="pubmed">37947944</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Hu Y, Li X, Ju B. A comprehensive analysis of the KLRB1 expression and its clinical implication in testicular germ cell tumors: a review. Medicine. 2024;103:e37688. 10.1097/MD.0000000000037688.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11018193</ArticleId><ArticleId IdType="pubmed">38608099</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherman BT, Hao M, Qiu J, Jiao X, Baseler MW, Lane HC, Imamichi T, Chang W. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022;50:W216–21. 10.1093/nar/gkac194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9252805</ArticleId><ArticleId IdType="pubmed">35325185</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44–57. 10.1038/nprot.2008.211.</Citation><ArticleIdList><ArticleId IdType="pubmed">19131956</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu H, Zhou Q, He J, Jiang Z, Peng C, Tong R, Shi J. Recent advances in the development of protein-protein interactions modulators: mechanisms and clinical trials. Signal Transduct Target Ther. 2020;5:213. 10.1038/s41392-020-00315-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7511340</ArticleId><ArticleId IdType="pubmed">32968059</ArticleId></ArticleIdList></Reference><Reference><Citation>De Las Rivas J, Fontanillo C. Protein-protein interaction networks: unraveling the wiring of molecular machines within the cell. Brief Funct Genomics. 2012;11:489–96. 10.1093/bfgp/els036.</Citation><ArticleIdList><ArticleId IdType="pubmed">22908212</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Q, Lin R, Chen Y, Lv Q, Zhang J, Zhai J, Xu W, Wang W. SARS-CoV-2 induces cytokine storm hyperinflammatory responses in RA patients through pyroptosis. Front Immunol. 2022;13:1058884. 10.3389/fimmu.2022.1058884.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9751040</ArticleId><ArticleId IdType="pubmed">36532040</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Yang Y, Fang Z, Hu Y-S, Zhang L, Wang J. Detecting pathway relationship in the context of human protein-protein interaction network and its application to Parkinson’s disease. Methods. 2017;131:93–103. 10.1016/j.ymeth.2017.08.001.</Citation><ArticleIdList><ArticleId IdType="pubmed">28790017</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos A, Tsafou KP, Kuhn M, Bork P, Jensen LJ, von Mering C. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43:D447-52. 10.1093/nar/gku1003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4383874</ArticleId><ArticleId IdType="pubmed">25352553</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, He M, Wang J, Liu S, Cheng H, Cheng Y. Predicting of disease genes for gestational diabetes mellitus based on network and functional consistency. Eur J Obstet Gynecol Reprod Biol. 2015;186:91–6. 10.1016/j.ejogrb.2014.12.016.</Citation><ArticleIdList><ArticleId IdType="pubmed">25666344</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozhilova LV, Whitmore AV, Wray J, Reinert G, Deane CM. Measuring rank robustness in scored protein interaction networks. BMC Bioinformatics. 2019;20:446. 10.1186/s12859-019-3036-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6714100</ArticleId><ArticleId IdType="pubmed">31462221</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–504. 10.1101/gr.1239303.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC403769</ArticleId><ArticleId IdType="pubmed">14597658</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin C-H, Chen S-H, Wu H-H, Ho C-W, Ko M-T, Lin C-Y. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8 Suppl 4(Suppl 4):S11. 10.1186/1752-0509-8-S4-S11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4290687</ArticleId><ArticleId IdType="pubmed">25521941</ArticleId></ArticleIdList></Reference><Reference><Citation>Trifonova OP, Lokhov PG, Archakov AI. Metabolic profiling of human blood. Biomed Khim. 2014;60:281–94. 10.18097/pbmc20146003281.</Citation><ArticleIdList><ArticleId IdType="pubmed">25019391</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Liu H, Ning S, Wei C, Li J, Wei W, Zhang L. The high ratio of the plasma miR-96/miR-99b correlated with poor prognosis in patients with metastatic colorectal Cancer. Front Mol Biosci. 2021;8:799060. 10.3389/fmolb.2021.799060.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8762210</ArticleId><ArticleId IdType="pubmed">35047559</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Narayan R, Corsello SM, Peck DD, Natoli TE, Lu X, Gould J, Davis JF, Tubelli AA, Asiedu JK, Lahr DL, Hirschman JE, Liu Z, Donahue M, Julian B, Khan M, Wadden D, Smith IC, Lam D, Liberzon A, Toder C, Bagul M, Orzechowski M, Enache OM, Piccioni F, Johnson SA, Lyons NJ, Berger AH, Shamji AF, Brooks AN, Vrcic A, Flynn C, Rosains J, Takeda DY, Hu R, Davison D, Lamb J, Ardlie K, Hogstrom L, Greenside P, Gray NS, Clemons PA, Silver S, Wu X, Zhao W-N, Read-Button W, Wu X, Haggarty SJ, Ronco LV, Boehm JS, Schreiber SL, Doench JG, Bittker JA, Root DE, Wong B, Golub TR. A next generation connectivity map: L1000 platform and the first 1,000,000 profiles. Cell. 2017;171:1437–52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5990023</ArticleId><ArticleId IdType="pubmed">29195078</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, Li Q, Shoemaker BA, Thiessen PA, Yu B, Zaslavsky L, Zhang J, Bolton EE. PubChem 2023 update. Nucleic Acids Res. 2023;51:D1373-80. 10.1093/nar/gkac956.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9825602</ArticleId><ArticleId IdType="pubmed">36305812</ArticleId></ArticleIdList></Reference><Reference><Citation>Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31:455–61. 10.1002/jcc.21334.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3041641</ArticleId><ArticleId IdType="pubmed">19499576</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkins JM, Santaguida S, Musacchio A, Knapp S. Crystal structure of human aurora B in complex with INCENP and VX-680. J Med Chem. 2012;55:7841–8. 10.1021/jm3008954.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3621106</ArticleId><ArticleId IdType="pubmed">22920039</ArticleId></ArticleIdList></Reference><Reference><Citation>Wendorff TJ, Schmidt BH, Heslop P, Austin CA, Berger JM. The structure of DNA-bound human topoisomerase II alpha: conformational mechanisms for coordinating inter-subunit interactions with DNA cleavage. J Mol Biol. 2012;424:109–24. 10.1016/j.jmb.2012.07.014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3584591</ArticleId><ArticleId IdType="pubmed">22841979</ArticleId></ArticleIdList></Reference><Reference><Citation>Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The protein data bank. Nucleic Acids Res. 2000;28:235–42. 10.1093/nar/28.1.235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC102472</ArticleId><ArticleId IdType="pubmed">10592235</ArticleId></ArticleIdList></Reference><Reference><Citation>Burley SK, Bhikadiya C, Bi C, Bittrich S, Chao H, Chen L, Craig PA, Crichlow GV, Dalenberg K, Duarte JM, Dutta S, Fayazi M, Feng Z, Flatt JW, Ganesan S, Ghosh S, Goodsell DS, Green RK, Guranovic V, Henry J, Hudson BP, Khokhriakov I, Lawson CL, Liang Y, Lowe R, Peisach E, Persikova I, Piehl DW, Rose Y, Sali A, Segura J, Sekharan M, Shao C, Vallat B, Voigt M, Webb B, Westbrook JD, Whetstone S, Young JY, Zalevsky A, Zardecki C. RCSB Protein Data Bank (RCSB.org): delivery of experimentally-determined PDB structures alongside one million computed structure models of proteins from artificial intelligence/machine learning. Nucleic Acids Res. 2023;51:D488-508. 10.1093/nar/gkac1077.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9825554</ArticleId><ArticleId IdType="pubmed">36420884</ArticleId></ArticleIdList></Reference><Reference><Citation>Laskowski RA, Swindells MB. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model. 2011;51:2778–86. 10.1021/ci200227u.</Citation><ArticleIdList><ArticleId IdType="pubmed">21919503</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace AC, Laskowski RA, Thornton JM. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng. 1995;8:127–34. 10.1093/protein/8.2.127.</Citation><ArticleIdList><ArticleId IdType="pubmed">7630882</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Zu G, Yu Y, Tang J, Han T, Zhang C. Curcumin’s mechanism of action against ischemic stroke: a network pharmacology and molecular dynamics study. PLoS ONE. 2023;18:e0280112. 10.1371/journal.pone.0280112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9812305</ArticleId><ArticleId IdType="pubmed">36598916</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Jiao Y, Yang M, Wu L, Long G, Hu W. Network Pharmacology, Molecular Docking and Molecular Dynamics to explore the potential immunomodulatory mechanisms of deer Antler. Int J Mol Sci. 2023;24:24. 10.3390/ijms241210370.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10299714</ArticleId><ArticleId IdType="pubmed">37373516</ArticleId></ArticleIdList></Reference><Reference><Citation>Yazdanpanah F, Hamblin MR, Rezaei N. The immune system and COVID-19: friend or foe? Life Sci. 2020;256:117900. 10.1016/j.lfs.2020.117900.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7266583</ArticleId><ArticleId IdType="pubmed">32502542</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan G-C, Cai L, Elowitz M, Enver T, Fan G, Guo G, Irizarry R, Kharchenko P, Kim J, Orkin S, Quackenbush J, Saadatpour A, Schroeder T, Shivdasani R, Tirosh I. Challenges and emerging directions in single-cell analysis. Genome Biol. 2017;18:84. 10.1186/s13059-017-1218-y.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5421338</ArticleId><ArticleId IdType="pubmed">28482897</ArticleId></ArticleIdList></Reference><Reference><Citation>Raje N, Anderson K, Einsele H, Efebera Y, Gay F, Hammond SP, Lesokhin AM, Lonial S, Ludwig H, Moreau P, Patel K, Ramasamy K, Mateos M-V. Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel. Blood Cancer J. 2023;13:116. 10.1038/s41408-023-00879-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10394080</ArticleId><ArticleId IdType="pubmed">37528088</ArticleId></ArticleIdList></Reference><Reference><Citation>N.S. Brunetti, G.G. Davanzo, D. de Moraes, A.J.R. Ferrari, G.F. Souza, S.P. Muraro, T.L. Knittel, V.O. Boldrini, L.B. Monteiro, J.V. Virgílio-da-Silva, G.S. Profeta, N.S. Wassano, L. Nunes Santos, V.C. Carregari, A.H.S. Dias, F.P. Veras, L.A. Tavares, J. Forato, I.M.S. Castro, L.C. Silva-Costa, A.C. Palma, E. Mansour, R.G. Ulaf, A.F. Bernardes, T.A. Nunes, L.C. Ribeiro, M. V Agrela, M.L. Moretti, L.I. Buscaratti, F. Crunfli, R.G. Ludwig, J.A. Gerhardt, N. Munhoz-Alves, A.M. Marques, R. Sesti-Costa, M.R. Amorim, D.A. Toledo-Teixeira, P.L. Parise, M.C. Martini, K. Bispos-Dos-Santos, C.L. Simeoni, F. Granja, V.C. Silvestrini, E.B. de Oliveira, V.M. Faca, M. Carvalho, B.G. Castelucci, A.B. Pereira, L.D. Coimbra, M.M.G. Dias, P.B. Rodrigues, A.B.S.P. Gomes, F.B. Pereira, L.M.B. Santos, L.-M. Bloyet, S. Stumpf, M.C. Pontelli, S. Whelan, A.C. Sposito, R.F. Carvalho, A.S. Vieira, M.A.R. Vinolo, A. Damasio, L. Velloso, A.C.M. Figueira, L.L.P. da Silva, T.M. Cunha, H.I. Nakaya, H. Marques-Souza, R.E. Marques, D. Martins-de-Souza, M.S. Skaf, J.L. Proenca-Modena, P.M.M. Moraes-Vieira, M.A. Mori, A.S. Farias. SARS-CoV-2 uses CD4 to infect T helper lymphocytes. Elife 2023;12. 10.7554/eLife.84790.</Citation></Reference><Reference><Citation>Santos AF, Póvoa P, Paixão P, Mendonça A, Taborda-Barata L. Changes in Glycolytic Pathway in SARS-COV 2 infection and their importance in understanding the severity of COVID-19. Front Chem. 2021;9:685196. 10.3389/fchem.2021.685196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8461303</ArticleId><ArticleId IdType="pubmed">34568275</ArticleId></ArticleIdList></Reference><Reference><Citation>Alahdal M, Elkord E. Promising use of immune cell-derived exosomes in the treatment of SARS-CoV-2 infections. Clin Transl Med. 2022;12:e1026. 10.1002/ctm2.1026.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9393056</ArticleId><ArticleId IdType="pubmed">35988156</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P. SARS-CoV-2 infections in children: understanding diverse outcomes. Immunity. 2022;55:201–9. 10.1016/j.immuni.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8769938</ArticleId><ArticleId IdType="pubmed">35093190</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai W, Guo C, Wang Y, Li Y, Xie R, Wu J, Yao B, Xie D, He L, Li Y, Huang H, Wang Y, Liu S. Identification of hub genes and pathways in lung metastatic colorectal cancer. BMC Cancer. 2023;23:323. 10.1186/s12885-023-10792-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10080892</ArticleId><ArticleId IdType="pubmed">37024866</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Q, Li W, Yu W, Zeng M, Liu J, Xu P. Analysis and identification of potential type II helper T cell (Th2)-Related key genes and therapeutic agents for COVID-19. Comput Biol Med. 2022;150:106134. 10.1016/j.compbiomed.2022.106134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9528635</ArticleId><ArticleId IdType="pubmed">36201886</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawyers CL. The cancer biomarker problem. Nature. 2008;452:548–52. 10.1038/nature06913.</Citation><ArticleIdList><ArticleId IdType="pubmed">18385728</ArticleId></ArticleIdList></Reference><Reference><Citation>Goossens N, Nakagawa S, Sun X, Hoshida Y. Cancer biomarker discovery and validation. Transl Cancer Res. 2015;4:256–69. 10.3978/j.issn.2218-676X.2015.06.04.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4511498</ArticleId><ArticleId IdType="pubmed">26213686</ArticleId></ArticleIdList></Reference><Reference><Citation>Bensalah K, Montorsi F, Shariat SF. Challenges of cancer biomarker profiling. Eur Urol. 2007;52:1601–9. 10.1016/j.eururo.2007.09.036.</Citation><ArticleIdList><ArticleId IdType="pubmed">17919807</ArticleId></ArticleIdList></Reference><Reference><Citation>Mäbert K, Cojoc M, Peitzsch C, Kurth I, Souchelnytskyi S, Dubrovska A. Cancer biomarker discovery: current status and future perspectives. Int J Radiat Biol. 2014;90:659–77. 10.3109/09553002.2014.892229.</Citation><ArticleIdList><ArticleId IdType="pubmed">24524284</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurung AB, Ali MA, Lee J, Farah MA, Al-Anazi KM. An updated review of computer-aided drug design and its application to COVID-19. Biomed Res Int. 2021;2021:8853056. 10.1155/2021/8853056.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8241505</ArticleId><ArticleId IdType="pubmed">34258282</ArticleId></ArticleIdList></Reference><Reference><Citation>Basak SC. Recent developments and future directions at current computer aided drug design. Curr Comput Aided Drug Des. 2013;9:1. 10.2174/1573409911309010001.</Citation><ArticleIdList><ArticleId IdType="pubmed">23905927</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabe VT, Ntombela T, Jhamba LA, Maguire GEM, Govender T, Naicker T, Kruger HG. Current trends in computer aided drug design and a highlight of drugs discovered via computational techniques: a review. Eur J Med Chem. 2021;224:113705. 10.1016/j.ejmech.2021.113705.</Citation><ArticleIdList><ArticleId IdType="pubmed">34303871</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng X-Y, Zhang H-X, Mezei M, Cui M. Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des. 2011;7:146–57. 10.2174/157340911795677602.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3151162</ArticleId><ArticleId IdType="pubmed">21534921</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z-X, Yang Y, Wang J-Q, Zhou W-M, Chen J, Fu Y-G, Patel K, Chen Z-S, Zhang J-Y. Elevated ABCB1 expression confers acquired resistance to Aurora kinase inhibitor GSK-1070916 in Cancer cells. Front Pharmacol. 2020;11:615824. 10.3389/fphar.2020.615824.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7841342</ArticleId><ArticleId IdType="pubmed">33519482</ArticleId></ArticleIdList></Reference><Reference><Citation>Uitdehaag JCM, de Roos JADM, van Doornmalen AM, Prinsen MBW, Spijkers-Hagelstein JAP, de Vetter JRF, de Man J, Buijsman RC, Zaman GJR. Selective targeting of CTNBB1-, KRAS- or MYC-Driven cell growth by combinations of existing drugs. PLoS ONE. 2015;10:e0125021. 10.1371/journal.pone.0125021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4446296</ArticleId><ArticleId IdType="pubmed">26018524</ArticleId></ArticleIdList></Reference><Reference><Citation>Chhajer R, Bhattacharyya A, Didwania N, Shadab M, Das N, Palit P, Vaidya T, Ali N. Leishmania Donovani Aurora kinase: a promising therapeutic target against visceral leishmaniasis. Biochim Biophys Acta. 2016;1860:1973–88. 10.1016/j.bbagen.2016.06.005.</Citation><ArticleIdList><ArticleId IdType="pubmed">27288586</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan Y, Fu H, Huang J, Yin N, Liu L, Liu X. TOP2A deficiency leads to human recurrent spontaneous abortion and growth retardation of mouse pre-implantation embryos. Mol Med. 2022;28:165. 10.1186/s10020-022-00592-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9805267</ArticleId><ArticleId IdType="pubmed">36585615</ArticleId></ArticleIdList></Reference><Reference><Citation>de Campos-Nebel M, Larripa I, González-Cid M. Topoisomerase II-mediated DNA damage is differently repaired during the cell cycle by non-homologous end joining and homologous recombination. PLoS ONE. 2010;5:5. 10.1371/journal.pone.0012541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2932731</ArticleId><ArticleId IdType="pubmed">20824055</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadia TM, Yang H, Ferrajoli A, Maddipotti S, Schroeder C, Madden TL, Holleran JL, Egorin MJ, Ravandi F, Thomas DA, Newsome W, Sanchez-Gonzalez B, Zwiebel JA, Espinoza-Delgado I, Kantarjian HM, Garcia-Manero G. A phase I study of vorinostat in combination with idarubicin in relapsed or refractory leukaemia. Br J Haematol. 2010;150:72–82. 10.1111/j.1365-2141.2010.08211.x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4124904</ArticleId><ArticleId IdType="pubmed">20456355</ArticleId></ArticleIdList></Reference><Reference><Citation>Eleftheriou P, Amanatidou D, Petrou A, Geronikaki A. Silico evaluation of the effectivity of approved protease inhibitors against the Main protease of the Novel SARS-CoV-2 Virus. Molecules. 2020;25:25. 10.3390/molecules25112529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7321236</ArticleId><ArticleId IdType="pubmed">32485894</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganou CA, Eleftheriou PT, Theodosis-Nobelos P, Fesatidou M, Geronikaki AA, Lialiaris T, Rekka EA. Docking analysis targeted to the whole enzyme: an application to the prediction of inhibition of PTP1B by thiomorpholine and thiazolyl derivatives. SAR QSAR Environ Res. 2018;29:133–49. 10.1080/1062936X.2017.1414874.</Citation><ArticleIdList><ArticleId IdType="pubmed">29347844</ArticleId></ArticleIdList></Reference><Reference><Citation>Eleftheriou P, Petrou A, Geronikaki A, Liaras K, Dirnali S, Anna M. Prediction of enzyme inhibition and mode of inhibitory action based on calculation of distances between hydrogen bond donor/acceptor groups of the molecule and docking analysis: an application on the discovery of novel effective PTP1B inhibitors. SAR QSAR Environ Res. 2015;26:557–76. 10.1080/1062936X.2015.1074939.</Citation><ArticleIdList><ArticleId IdType="pubmed">26294069</ArticleId></ArticleIdList></Reference><Reference><Citation>Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet. 2020;395:1225–8. 10.1016/S0140-6736(20)30627-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102589</ArticleId><ArticleId IdType="pubmed">32178769</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Jaffe A, Li H, Lindenbaum O, Sefik E, Jackson R, Cheng X, Flavell RA, Kluger Y. Detection of differentially abundant cell subpopulations in scRNA-seq data. Proc Natl Acad Sci U S A. 2021;118:118. 10.1073/pnas.2100293118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8179149</ArticleId><ArticleId IdType="pubmed">34001664</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang G, Xiong Z, Yang F, Zheng X, Zong W, Li R, Bao Y. Identification of COVID-19-associated DNA methylation variations by integrating methylation array and scRNA-Seq data at cell-type resolution. Genes (Basel). 2022;13:1109. 10.3390/genes13071109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9322889</ArticleId><ArticleId IdType="pubmed">35885892</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu K, Zhang W, Wang C, Hu L, Wang R, Wang C, Tang L, Zhou G, Zou B, Xie H, Tang J, Guan X. Integrative analyses of scRNA-seq and scATAC-seq reveal CXCL14 as a key regulator of lymph node metastasis in breast cancer. Hum Mol Genet. 2021;30:370–80. 10.1093/hmg/ddab042.</Citation><ArticleIdList><ArticleId IdType="pubmed">33564857</ArticleId></ArticleIdList></Reference><Reference><Citation>Lohr M, Edlund K, Botling J, Hammad S, Hellwig B, Othman A, Berglund A, Lambe M, Holmberg L, Ekman S, Bergqvist M, Pontén F, Cadenas C, Marchan R, Hengstler JG, Rahnenführer J, Micke P. The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancer. Cancer Lett. 2013;333:222–8. 10.1016/j.canlet.2013.01.036.</Citation><ArticleIdList><ArticleId IdType="pubmed">23370224</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt M, Böhm D, von Törne C, Steiner E, Puhl A, Pilch H, Lehr H-A, Hengstler JG, Kölbl H, Gehrmann M. The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer Res. 2008;68:5405–13. 10.1158/0008-5472.CAN-07-5206.</Citation><ArticleIdList><ArticleId IdType="pubmed">18593943</ArticleId></ArticleIdList></Reference><Reference><Citation>Fristedt R, Borg D, Hedner C, Berntsson J, Nodin B, Eberhard J, Micke P, Jirström K. Prognostic impact of tumour-associated B cells and plasma cells in oesophageal and gastric adenocarcinoma. J Gastrointest Oncol. 2016;7:848–59. 10.21037/jgo.2016.11.07.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5177573</ArticleId><ArticleId IdType="pubmed">28078109</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Shao B. Circulating lncRNA IFNG-AS1 expression correlates with increased disease risk, higher disease severity and elevated inflammation in patients with coronary artery disease. J Clin Lab Anal. 2018;32:e22452. 10.1002/jcla.22452.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6817098</ArticleId><ArticleId IdType="pubmed">29744951</ArticleId></ArticleIdList></Reference><Reference><Citation>Padua D, Mahurkar-Joshi S, Law IKM, Polytarchou C, Vu JP, Pisegna JR, Shih D, Iliopoulos D, Pothoulakis C. A long noncoding RNA signature for ulcerative colitis identifies IFNG-AS1 as an enhancer of inflammation. Am J Physiol Gastrointest Liver Physiol. 2016;311:G446-457. 10.1152/ajpgi.00212.2016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5076004</ArticleId><ArticleId IdType="pubmed">27492330</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke DF, Bryant P, Barrio-Hernandez I, Memon D, Pozzati G, Shenoy A, Zhu W, Dunham AS, Albanese P, Keller A, Scheltema RA, Bruce JE, Leitner A, Kundrotas P, Beltrao P, Elofsson A. Nat Struct Mol Biol. 2023;30:216–25. 10.1038/s41594-022-00910-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9935395</ArticleId><ArticleId IdType="pubmed">36690744</ArticleId></ArticleIdList></Reference><Reference><Citation>Spirin V, Mirny LA. Protein complexes and functional modules in molecular networks. Proc Natl Acad Sci U S A. 2003;100:12123–8. 10.1073/pnas.2032324100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC218723</ArticleId><ArticleId IdType="pubmed">14517352</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal P, Sambaturu N, Olgun G, Hannenhalli S, Path-Based A. Analysis of infected cell line and COVID-19 patient transcriptome reveals novel potential targets and drugs against SARS-CoV-2. Front Immunol. 2022;13:918817. 10.3389/fimmu.2022.918817.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9284228</ArticleId><ArticleId IdType="pubmed">35844595</ArticleId></ArticleIdList></Reference><Reference><Citation>Roshan P, Kuppa S, Mattice JR, Kaushik V, Chadda R, Pokhrel N, Tumala BR, Biswas A, Bothner B, Antony E, Origanti S. An Aurora B-RPA signaling axis secures chromosome segregation fidelity. Nat Commun. 2023;14:3008. 10.1038/s41467-023-38711-2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10212944</ArticleId><ArticleId IdType="pubmed">37230964</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirsch-Volders M, Fenech M. Inflammatory cytokine storms severity may be fueled by interactions of micronuclei and RNA viruses such as COVID-19 virus SARS-CoV-2. A hypothesis. Mutat Res Rev Mutat Res. 2021;788:108395. 10.1016/j.mrrev.2021.108395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8479308</ArticleId><ArticleId IdType="pubmed">34893160</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo X, Zhou L, Wu Y, Li J. KIF11 as a potential Pan-cancer Immunological Biomarker encompassing the Disease Staging, Prognoses, Tumor Microenvironment, and therapeutic responses. Oxid Med Cell Longev. 2022;2022(2764940):1. 10.1155/2022/2764940.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9893523</ArticleId><ArticleId IdType="pubmed">36742345</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Yu B, Qi F, Li F. KIF11 serves as an independent prognostic factor and therapeutic target for patients with lung adenocarcinoma. Front Oncol. 2021;11:670218. 10.3389/fonc.2021.670218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8103954</ArticleId><ArticleId IdType="pubmed">33968780</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabassum G, Singh P, Gurung R, Hakami MA, Alkhorayef N, Alsaiari AA, Alqahtani LS, Hasan MR, Rashid S, Kumar A, Dev K, Dohare R. Investigating the role of Kinesin family in lung adenocarcinoma via integrated bioinformatics approach. Sci Rep. 2023;13:9859. 10.1038/s41598-023-36842-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10276827</ArticleId><ArticleId IdType="pubmed">37330525</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Yu K, Zhang K, Niu M, Chen Q, Liu Y, Wang L, Zhang N, Li W, Zhong X, Li G, Wu S, Zhang J, Liu Y. O-GlcNAcylation promotes topoisomerase IIα catalytic activity in breast cancer chemoresistance. EMBO Rep. 2023;24:e56458. 10.15252/embr.202256458.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10328065</ArticleId><ArticleId IdType="pubmed">37249035</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson E, Reynolds G, Botting RA, Calero-Nieto FJ, Morgan MD, Tuong ZK, Bach K, Sungnak W, Worlock KB, Yoshida M, Kumasaka N, Kania K, Engelbert J, Olabi B, Spegarova JS, Wilson NK, Mende N, Jardine L, Gardner LCS, Goh I, Horsfall D, McGrath J, Webb S, Mather MW, Lindeboom RGH, Dann E, Huang N, Polanski K, Prigmore E, Gothe F, Scott J, Payne RP, Baker KF, Hanrath AT, Schim van der Loeff ICD, Barr AS, Sanchez-Gonzalez A, Bergamaschi L, Mescia F, Barnes JL, Kilich E, de Wilton A, Saigal A, Saleh A, Janes SM, Smith CM, Gopee N, Wilson C, Coupland P, Coxhead JM, Kiselev VY, van Dongen S, Bacardit J, King HW, Rostron AJ, Simpson AJ, Hambleton S, Laurenti E, Lyons PA, Meyer KB, Nikolić MZ, Duncan CJA, Smith KGC, Teichmann SA, Clatworthy MR, Marioni JC, Göttgens B, Haniffa M, Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) COVID-19 BioResource Collaboration. Single-cell multi-omics analysis of the immune response in COVID-19. Nat Med. 2021;27:904–16. 10.1038/s41591-021-01329-2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8121667</ArticleId><ArticleId IdType="pubmed">33879890</ArticleId></ArticleIdList></Reference><Reference><Citation>Samy A, Maher MA, Abdelsalam NA, Badr E. SARS-CoV-2 potential drugs, drug targets, and biomarkers: a viral-host interaction network-based analysis. Sci Rep. 2022;12:11934. 10.1038/s41598-022-15898-w.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9279364</ArticleId><ArticleId IdType="pubmed">35831333</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams ND, Adams JL, Burgess JL, Chaudhari AM, Copeland RA, Donatelli CA, Drewry DH, Fisher KE, Hamajima T, Hardwicke MA, Huffman WF, Koretke-Brown KK, Lai ZV, McDonald OB, Nakamura H, Newlander KA, Oleykowski CA, Parrish CA, Patrick DR, Plant R, Sarpong MA, Sasaki K, Schmidt SJ, Silva DJ, Sutton D, Tang J, Thompson CS, Tummino PJ, Wang JC, Xiang H, Yang J, Dhanak D. Discovery of GSK1070916, a potent and selective inhibitor of Aurora B/C kinase. J Med Chem. 2010;53:3973–4001. 10.1021/jm901870q.</Citation><ArticleIdList><ArticleId IdType="pubmed">20420387</ArticleId></ArticleIdList></Reference><Reference><Citation>Kallio MJ, McCleland ML, Stukenberg PT, Gorbsky GJ. Inhibition of aurora B kinase blocks chromosome segregation, overrides the spindle checkpoint, and perturbs microtubule dynamics in mitosis. Curr Biol. 2002;12:900–5. 10.1016/s0960-9822(02)00887-4.</Citation><ArticleIdList><ArticleId IdType="pubmed">12062053</ArticleId></ArticleIdList></Reference><Reference><Citation>Bock J-O, Ortea I. Re-analysis of SARS-CoV-2-infected host cell proteomics time-course data by impact pathway analysis and network analysis: a potential link with inflammatory response. Aging. 2020;12:11277–86. 10.18632/aging.103524.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7343490</ArticleId><ArticleId IdType="pubmed">32575076</ArticleId></ArticleIdList></Reference><Reference><Citation>de Cavalcante LT, da Fonseca GC, Amado Leon LA, Salvio AL, Brustolini OJ, Gerber AL, de Guimarães AP, Marques CAB, Fernandes RA, Ramos Filho CHF, Kader RL, Pimentel Amaro M, da Costa JP, Gonçalves S, Vieira Alves-Leon ATR, Vasconcelos. Buffy Coat Transcriptomic Analysis reveals alterations in host cell protein synthesis and cell cycle in severe COVID-19 patients. Int J Mol Sci. 2022;23. 10.3390/ijms232113588.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9659271</ArticleId><ArticleId IdType="pubmed">36362378</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y-J, Chang C-W, Chen M-J, Lai Y-C. Impact of COVID-19 on liver. World J Clin Cases. 2021;9:7998–8007. 10.12998/wjcc.v9.i27.7998.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8462210</ArticleId><ArticleId IdType="pubmed">34621856</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh N, Saha I, Plewczynski D. Unveiling the biomarkers of Cancer and COVID-19 and their regulations in different organs by integrating RNA-Seq expression and protein-protein interactions. ACS Omega. 2022;7:43589–602. 10.1021/acsomega.2c04389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9730762</ArticleId><ArticleId IdType="pubmed">36506181</ArticleId></ArticleIdList></Reference><Reference><Citation>Noor F, Ashfaq UA, Bakar A, Ul Haq W, Allemailem KS, Alharbi BF, Al-Megrin WAI. Tahir Ul Qamar, discovering common pathogenic processes between COVID-19 and HFRS by integrating RNA-seq differential expression analysis with machine learning. Front Microbiol. 2023;14:1175844. 10.3389/fmicb.2023.1175844.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10208410</ArticleId><ArticleId IdType="pubmed">37234545</ArticleId></ArticleIdList></Reference><Reference><Citation>Dean EA, Brown RA, Kaur P, Casaus DV. Viral clearance with Neutrophil Recovery in a patient with active COVID-19 infection and refractory Acute Myeloid Leukemia who underwent successful reinduction with Cytarabine/Idarubicin. Case Rep Oncol. 2022;15:705–12. 10.1159/000525766.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9459561</ArticleId><ArticleId IdType="pubmed">36157697</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Rashedi NAM, Munahi MG, Ah L, ALObaidi. Prediction of potential inhibitors against SARS-CoV-2 endoribonuclease: RNA immunity sensing. J Biomol Struct Dyn. 2022;40:4879–92. 10.1080/07391102.2020.1863265.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7784835</ArticleId><ArticleId IdType="pubmed">33357040</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandra A, Gurjar V, Qamar I, Singh N. Identification of potential inhibitors of SARS-COV-2 endoribonuclease (EndoU) from FDA approved drugs: a drug repurposing approach to find therapeutics for COVID-19. J Biomol Struct Dyn. 2021;39:4201–11. 10.1080/07391102.2020.1775127.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7298882</ArticleId><ArticleId IdType="pubmed">32462970</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>